The Reproducibility Crisis

Morgan McSweeney As Alex Woodell recently described, the preclinical research community is in a quiet crisis. Somewhere between 50% and 90% of results from early-stage academic cancer research are unable to be reproduced by industry scientists. Studies by several large multinational pharmaceutical companies and a number of other independent research groups have confirmed what they... Continue Reading →

The Reproducibility Project

Alex S. Woodell As members of the biomedical research community, we are all familiar with the basic structure of the scientific method. We make an observation that identifies a problem, form a hypothesis based on known information, perform experiments to test this hypothesis, then draw conclusions that drive future research. However, there is a fifth... Continue Reading →

Create a website or blog at WordPress.com

Up ↑